Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

317 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Outcomes of persistently active neovascular age-related macular degeneration treated with VEGF inhibitors: observational study data.
Barthelmes D, Walton R, Campain AE, Simpson JM, Arnold JJ, McAllister IL, Guymer RH, Hunyor AP, Essex RW, Morlet N, Gillies MC; Fight Retinal Blindness! Project Investigators. Barthelmes D, et al. Br J Ophthalmol. 2015 Mar;99(3):359-64. doi: 10.1136/bjophthalmol-2014-305514. Epub 2014 Sep 23. Br J Ophthalmol. 2015. PMID: 25249615 Free article.
Subthreshold Nanosecond Laser Intervention in Age-Related Macular Degeneration: The LEAD Randomized Controlled Clinical Trial.
Guymer RH, Wu Z, Hodgson LAB, Caruso E, Brassington KH, Tindill N, Aung KZ, McGuinness MB, Fletcher EL, Chen FK, Chakravarthy U, Arnold JJ, Heriot WJ, Durkin SR, Lek JJ, Harper CA, Wickremasinghe SS, Sandhu SS, Baglin EK, Sharangan P, Braat S, Luu CD; Laser Intervention in Early Stages of Age-Related Macular Degeneration Study Group. Guymer RH, et al. Among authors: chen fk. Ophthalmology. 2019 Jun;126(6):829-838. doi: 10.1016/j.ophtha.2018.09.015. Epub 2018 Sep 20. Ophthalmology. 2019. PMID: 30244144 Free article. Clinical Trial.
Secondary and Exploratory Outcomes of the Subthreshold Nanosecond Laser Intervention Randomized Trial in Age-Related Macular Degeneration: A LEAD Study Report.
Wu Z, Luu CD, Hodgson LAB, Caruso E, Brassington KH, Tindill N, Aung KZ, Harper CA, Wickremasinghe SS, Sandhu SS, McGuinness MB, Chen FK, Chakravarthy U, Arnold JJ, Heriot WJ, Durkin SR, Wintergerst MWM, Gorgi Zadeh S, Schultz T, Finger RP, Cohn AC, Baglin EK, Sharangan P, Guymer RH; LEAD Study Group. Wu Z, et al. Among authors: chen fk. Ophthalmol Retina. 2019 Dec;3(12):1026-1034. doi: 10.1016/j.oret.2019.07.008. Epub 2019 Jul 22. Ophthalmol Retina. 2019. PMID: 31582304 Clinical Trial.
Association between Patient-Reported Outcomes and Time to Late Age-Related Macular Degeneration in the Laser Intervention in Early Stages of Age-Related Macular Degeneration Study.
McGuinness MB, Finger RP, Wu Z, Luu CD, Chen FK, Arnold JJ, Chakravarthy U, Guymer RH; Laser Intervention in Early Stages of Age-Related Macular Degeneration Study Group. McGuinness MB, et al. Among authors: chen fk. Ophthalmol Retina. 2020 Sep;4(9):881-888. doi: 10.1016/j.oret.2020.03.015. Epub 2020 Mar 30. Ophthalmol Retina. 2020. PMID: 32418845 Clinical Trial.
Subthreshold Nanosecond Laser in Age-Related Macular Degeneration: Observational Extension Study of the LEAD Clinical Trial.
Guymer RH, Chen FK, Hodgson LAB, Caruso E, Harper CA, Wickremashinghe SS, Cohn AC, Sivarajah P, Tindill N, Luu CD, Wu Z; LEAD Study Group. Guymer RH, et al. Among authors: chen fk. Ophthalmol Retina. 2021 Dec;5(12):1196-1203. doi: 10.1016/j.oret.2021.02.015. Epub 2021 Mar 1. Ophthalmol Retina. 2021. PMID: 33662615 Clinical Trial.
317 results